IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy.

Lotrich, Francis E

IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy. [electronic resource] - Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research Mar 2011 - 331-6 p. digital

Publication Type: Journal Article

1557-7465

10.1089/jir.2010.0074 doi


Adult
Antiviral Agents--administration & dosage
Female
Genotype
Hepacivirus
Hepatitis C--drug therapy
Humans
Interferon-alpha--administration & dosage
Interferons
Interleukins--genetics
Male
Middle Aged
Polymorphism, Single Nucleotide